Literature DB >> 18591449

Intracoronary administration of abciximab in ST-elevation myocardial infarction.

C Michael Gibson, Cafer Zorkun, Vijayalakshmi Kunadian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18591449     DOI： 10.1161/CIRCULATIONAHA.108.780718

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

Review 1.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

2.  Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction.

Authors:  Mohammad Hasan Namazi; Morteza Safi; Hosein Vakili; Habibollah Saadat; Esfandiar Karimi; Ramin Khameneh Bagheri
Journal:  J Tehran Heart Cent       Date:  2013-07-30

3.  The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction; A randomized clinical trial study.

Authors:  Abdullatef Ghazal; Hasan Shemirani; Afshin Amirpour; Mohammad Kermani-Alghoraishi
Journal:  ARYA Atheroscler       Date:  2019-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.